AU2003220557A8 - Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses - Google Patents

Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Info

Publication number
AU2003220557A8
AU2003220557A8 AU2003220557A AU2003220557A AU2003220557A8 AU 2003220557 A8 AU2003220557 A8 AU 2003220557A8 AU 2003220557 A AU2003220557 A AU 2003220557A AU 2003220557 A AU2003220557 A AU 2003220557A AU 2003220557 A8 AU2003220557 A8 AU 2003220557A8
Authority
AU
Australia
Prior art keywords
compositions
methods
multiple sclerosis
derived proteins
immunoglobulin derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003220557A
Other versions
AU2003220557A1 (en
Inventor
George Tracey
David Peritt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of AU2003220557A8 publication Critical patent/AU2003220557A8/en
Publication of AU2003220557A1 publication Critical patent/AU2003220557A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003220557A 2002-03-26 2003-03-26 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses Abandoned AU2003220557A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36789602P 2002-03-26 2002-03-26
US60/367,896 2002-03-26
PCT/US2003/009460 WO2003082206A2 (en) 2002-03-26 2003-03-26 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Publications (2)

Publication Number Publication Date
AU2003220557A8 true AU2003220557A8 (en) 2003-10-13
AU2003220557A1 AU2003220557A1 (en) 2003-10-13

Family

ID=28675412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003220557A Abandoned AU2003220557A1 (en) 2002-03-26 2003-03-26 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Country Status (3)

Country Link
EP (1) EP1494712A4 (en)
AU (1) AU2003220557A1 (en)
WO (1) WO2003082206A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018195A1 (en) * 2002-03-26 2004-01-29 Griswold Don Edgar Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
JP2007515939A (en) * 2003-05-09 2007-06-21 セントカー・インコーポレーテツド IL-23p40-specific immunoglobulin derived proteins, compositions, methods and uses
WO2007147019A2 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
MX2011003347A (en) * 2008-09-30 2011-05-25 Baylor Res Inst Methods to reduce b-helper t cells to treat autoimmune diseases.
HUE026269T2 (en) * 2010-05-27 2016-06-28 Janssen Biotech Inc Insulin-like growth factor 1 receptor binding peptides
KR20120093002A (en) 2011-02-14 2012-08-22 (주)에이티젠 Method for diagnosing cancer and diagnosis kit using measurement of nk cell activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140094647A (en) * 1999-03-25 2014-07-30 아비에 도이치란트 게엠베하 운트 콤파니 카게 Human antibodies that bind human IL-12 and methods for producing
US6902734B2 (en) * 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof
US20030157105A1 (en) * 2001-05-30 2003-08-21 Carton Jill M. Anti-p40 immunglobulin derived proteins, compositions, methods and uses

Also Published As

Publication number Publication date
WO2003082206A2 (en) 2003-10-09
EP1494712A2 (en) 2005-01-12
AU2003220557A1 (en) 2003-10-13
WO2003082206A3 (en) 2004-03-04
EP1494712A4 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
EP1623011A4 (en) IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
AU2003223497A8 (en) Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
EP1578930A4 (en) Cngh0004 polypeptides, antibodies, compositions, methods and uses
EP1644416A4 (en) Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
AU2002314825A1 (en) Anti-p40 immunoglobulin derived proteins, compositions, methods and uses
EP1542699A4 (en) Compounds, compositions, and methods employing same
HK1079213A1 (en) Anti-il-6 antibodies, compositions, methods and uses
AU2003262747A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
AU2003270015A8 (en) Compounds, compositions, and methods
AU2002359495A8 (en) Anti-tnf antibodies, compositions, methods and uses
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
EP1711527A4 (en) Hla-dr-specific antibodies, compositions and methods
AU2003290507A8 (en) Compounds, compositions and methods
EP1539792A4 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
AU2003277079A8 (en) Compounds, compositions, and methods
AU2003237332A8 (en) Anti-relp fusion antibodies, compositions, methods and uses
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
IL156263A0 (en) Livin-derived peptides, compositions and uses thereof
AU2003220557A8 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
AU2003267169A8 (en) Compounds, compositions and methods
AU2003297670A8 (en) P53-associated parkin-like cytoplasmic protein, and related compositions and methods
AU2003218432A8 (en) Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
EP1501870A4 (en) Rsv proteins, antibodies, compositions, methods and uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase